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Abstract
Sea-derived materials have promising applications in the medical, pharmaceutical and 
biotechnological fields. Fish roe, e.g., is a highly nutritional product, presenting diverse beneficial 
effects for human health. Therefore, this work explored extracts of sardine (Sardina pilchardus) roe, 
due to the well-known health benefits of this fish, to produce novel and promising delivery systems. 
After morphological, histological and histochemical characterization of sardine roe, their lipids were 
extracted using two different approaches, namely Bligh and Dyer (BD) and methyl-tert-butyl ether 
(MTBE) methods. Gas chromatography/mass spectrometry analyses demonstrated that lipid extracts 
contain several fatty acids, such as ω3 polyunsaturated fatty acids. The lipids, specially phospholipids, 
were used to produce multilamellar liposomes (MLVs). These delivery systems presented size 
heterogeneity, a negative surface charge and ability to control the release of the encapsulated anti-
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3inflammatory drug, namely celecoxib. Biological assays indicated that MLVs produced with MTBE 
lipidic extracts presented a better cytocompatibility than those obtained by the BD method. This can 
be further improved if the lipid extracts are processed by chemical extraction. Therefore, sardine roe-
derived lipids can produce drug delivery systems with the potential to be applied in the biomedical 
field.
Keywords
Sardine roe; Bligh and Dyer; methyl-tert-butyl ether; fatty acids; liposomes; cytocompatibility 
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4Introduction
Sea is still a largely unexploited resource of novel and promising biomaterials for 
biotechnological, pharmaceutical and medical applications. In addition to their large 
biodiversity, marine biomaterials are frequently biodegradable and biocompatible. An 
example of them is the squid viscera lecithin, which is usefully used in the food and 
pharmaceutical industries, due to its high amounts in polyunsaturated fatty acids as well as 
high oxidative stability.1 Salmon lecithin nanoliposomes were also used to encapsulate TGF-
β1 (a protein with a crucial role in cell signaling), demonstrating the potential to be used in 
regenerative medicine.2 Other successful and well-recognized examples of marine 
biomaterials with biomedical applications are chitosan, collagen, and fucoidan.3-5
A promising raw marine material is fish roe that is the fish eggs included in the original ovarian 
sac. It is a highly nutritional valued product and it is expanding in international and national 
markets.6 Despite fish roe was considered in the past a by-product of the fish transformation 
industry, nowadays it is considered an important nutritional product. Caviar is the best-known 
form of fish roe products.6 Fish roe is rich in proteins containing essential amino acids, long-
chain ω3 polyunsaturated fatty acids (PUFA), mainly docosahexaenoic acid (DHA; C22:6ω3) 
and eicosapentaenoic acid (EPA; C20:5ω3), phosphatidylcholine, cholesterol, antioxidants 
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5(e.g. carotenoids and tocopherols) and minerals (e.g. iodine).7-9 The fish roe lipids have 
several potentialities, for instance, a growth inhibitory effect on colon cancer cells10 and an 
improvement in the liver function of patients with chronic liver diseases.11 Moreover, fish roe 
possesses antioxidant and immunostimulating properties.12 Fish roe fatty acids are also 
useful in the prevention of cardiovascular diseases13, in the improvement of visual function 
and learning ability,8  as cancer chemopreventive agents and in the treatment of mental 
disorders, type 2 diabetes, as well as inflammatory and autoimmune diseases.14 Additionally, 
fish roe lipids have been extensively used in the cosmetic field. For example, caviar extracts 
are in the cosmetic market since 1987.15 Consequently, fish roe derived-nutrients can be 
beneficial in functional and health foods, as well as in nutraceuticals and pharmaceutical 
formulations for various therapeutic applications. 
In this work, sardine roe was used as a source of marine lipids. Sardine (Sardina pilchardus) 
is a multiple spawning fish, and eggs are released in batches over a period that starts in 
October and lasts until April. Each spawning batch presents oocytes in different 
developmental stages, and females can release around 400,000 eggs per year.16-17 
Histochemical analysis of developmental oocytes was performed in this work to evaluate the 
distribution of the compounds of interest, such as lipids. Indeed, despite sardine being an 
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6excellent source of proteins, vitamins, minerals, and choline, this specie is one of the highest 
sources of ω3 PUFA.18-19 ω3 PUFA are well-known for their effects in disease prevention, 
during all stages of human development.14 In fact, they are crucial to maintain the cell 
membrane composition and normal cell functions.20 
Considering the above-mentioned features of sardine, and specifically of fish roe, this marine 
resource may be further exploited envisioning biomedical applications. For that, sardine roe-
derived lipids, and in particular phospholipids, were used to produce liposomes. Indeed, due 
to their biological and technological advantages, liposomes are considered one of the most 
successful drug-carrier systems, existing numerous formulations currently in clinical 
practice.21 There are several types of liposomes, being multilamellar (MLVs), large 
unilamellar (LUVs) and small unilamellar (SUVs) liposomes the most commonly used. MLVs 
consist of several concentric lipid bilayers, with a size range between 0.1 and 15 µm. LUVs 
and SUVs contain only a single bilayer membrane and a size ranging from 0.05 or 0.1 to 1 
µm, and from 25 to 50 nm, respectively.22-23 SUVs are less stable than the other types of liposomes, 
due to the high curvature and consequent high surface tension and anomalies in the packaging of 
lipids.23-24 Additionally, LUVs have a higher volume fraction for encapsulation than SUVs for the 
same lipid concentration.23 Despite LUVs homogeneity and higher encapsulation efficiency of 
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7hydrophilic compounds,25 MLVs have the advantage of incorporating considerable amounts 
of hydrophobic agents, since they contain larger lipid surfaces and number of membranes.26 
This type of liposomes also provides a more gradual and sustained drug release than LUVs, 
because their membranes are progressively degraded at the site of action.27 Additionally, Lu 
et al. stated that marine phospholipid based-liposomes can have advantageous features, 
such as better oxidative stability, higher bioavailability, and superior fluidity when compared 
to other types of liposomes.25 Indeed, many of the physical properties of the liposomes, such 
as stability, permeability and phase transition temperature, are intrinsically related to the 
length and saturation degree of their phospholipids. To obtain sardine roe-derived lipids, two 
different approaches were used, namely Bligh and Dyer (BD) and methyl-tert-butyl ether 
(MTBE) methods. The BD method is widely used for the extraction of lipids from marine 
tissues,28 however, the use of chloroform is one of its major drawbacks. On the other hand, 
the MTBE method uses a nontoxic solvent29 and presents a recovery of lipids similar to the 
BD method. Therefore, this environmentally friendly method can be a good candidate to 
replace the “gold-standard” Folch or BD protocols.30 The fatty acids profile of the lipidic 
extracts was analyzed by gas chromatography/mass spectrometry (GC/MS) and the 
phospholipid and phosphatidylcholine contents were determined using the phosphorous 
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8(Barlett method) and the LabAssay™ Phospholipid assays, respectively. The 
characterization of the MLVs produced by the thin film hydration method included the 
analyses of their size distribution, surface charge, morphology, and thermal properties. 
Additionally, the cytotoxicity of the MLVs was evaluated using L929 cells, a mammalian 
mouse lung fibroblast cell line. These cells were selected since they are widely used for 
preliminary cytotoxicity evaluation for a wide range of biomaterials.31 The entrapment 
efficiency and release profile studies of celecoxib into MLVs were also performed. This drug 
is a specific inhibitor of cyclooxygenase-2 that exhibits analgesic and anti-inflammatory 
activities.32 Celecoxib is poorly soluble in water and presents serious cardiovascular side 
effects. Consequently, the developed liposomes can improve the solubility and the 
bioavailability of this non-steroidal anti-inflammatory drug (NSAID), and reduce its side 
effects, increasing its therapeutic index. To the best of our knowledge, the present work is 
the first reporting this characterization of sardine roe-derived lipids and liposomes. 
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9Experimental Section
Materials 
Alcian Blue, ammonium molybdate, Dulbecco's modified Eagle's medium (DMEM), Fiske-
Subbarow reducer, HEPES hemisodium salt, Oil Red O, perchloric acid, phosphate buffer 
saline (PBS), osmium tetroxide, sodium carbonate, sodium sulfate, Supelco® 37 Component 
FAME Mix, tert-butyl methyl ether, tricosanoic acid and celecoxib was obtained from abcr 
GmbH, Karlsruhe, Germany. Acetonitrile HPLC grade and acetic acid were acquired from 
Fisher Chemical, Leicestershire, UK, and Panreac, Barcelona, Spain, respectively. Antibiotic-
Antimycotic, fetal bovine serum (FBS) and quant-iT™ Pico Green® dsDNA Assay Kit were 
obtained from Life Technologies, Carlsbad, CA. CellTiter 96® AQueous One Solution Cell 
Proliferation Assay was purchased from Promega, Madison, USA. Chloroform and methanol 
were obtained from Fisher Chemical, Loughborough, Leicestershire. Dimethyl sulfoxide 
(DMSO) and eosin were purchased from AMRESCO, Solon, USA and Applied biosystems, 
Warrington, UK, respectively. Formalin, hematoxylin and micro BCA™ Protein Assay kit were 
obtained from Thermo Fisher Scientific, Kalamazoo, MI. Glutaraldehyde 25% were obtained 
from Merck KGaA, Darmstadt, Germany. Acetone, ethanol, hexane and sulfuric acid were 
obtained from Carlo Erba Reagents, Val de Reuil, France. Hydrochloric acid and LabAssay™ 
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10
Phospholipid were purchased from Honeywell, Seelze, German and Wako, Osaka, Japan, 
respectively. Masson’s Trichome and paraffin were obtained from  Bio-optica, Milano, Italy.
Methods
Sample preparation
Fresh sardine (Sardina pilchardus) roe, captured at the Portuguese mainland coast, were 
kindly donated by a local fisherman in March or October 2017. Samples for lipid extraction 
were then weighed and stored at -20 ºC. 
Scanning electron microscopy analyses
Sardine roe samples were prepared for scanning electron microscopy (SEM) analyses, as 
described by Gwo et al. 33 Briefly, fresh sardine roe was fixed with 2.5% glutaraldehyde in 
0.01 M PBS for 4 h, at 4 ºC, and post fixed with 2% osmium tetroxide in the same buffer for 
2 h. Samples were then dehydrated using a series of increasing percentages of ethanol in 
water. Samples were submerged in acetone to dry before being sputter-coated with platinum 
(EM ACE600, Leica), and then they were analyzed by SEM (JSM-6010 LV, JEOL). 
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11
Histological and histochemical analyses
For histological analyses, fresh sardine roe was fixed in 10% buffered formalin for 2 days. 
After this period of time, samples were dehydrated using a series of increasing 
percentages of ethanol in water. Then, the dehydrated samples were embedded in paraffin 
and sectioned at 4 µm thickness (HM 560, Microm). Sections were then deparaffinized, 
rehydrated through a series of decreasing percentages of ethanol in water, and stained with 
Hematoxylin-eosin (HE), Alcian Blue (AB) or Masson’s Trichrome (MT) staining. HE 
staining was used for the study of the different stages of the sardine reproductive cycle 
(hematoxylin and eosin stain the acidic and basic components of the oocytes, respectively), 
AB for acidic glycosaminoglycans (GAGs) that are sulfated (pH 2.5), and MT for collagen 
fibers. Sardine roe was also cryostatically sectioned at 8-10 µm thickness for lipid detection. 
Oil Red O staining was used to detect general and neutral lipids.
Extraction of sardine roe derived-lipids
Bligh and Dyer Method
Extraction following the Bligh and Dyer (BD) method was performed as originally described.28 
Briefly, 100 g of a sample containing (or adjusted to contain) 80 g of water was homogenized 
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12
with 100 mL chloroform and 200 mL methanol. The solution was then rehomogenized with 
100 mL chloroform, and after that 100 mL water was added. The proportions of chloroform, 
methanol, and water before and after dilution were 1:2:0.8 and 2:2:1.8, respectively. After 
filtration (under vacuum), the final biphasic system was separated and the lower phase 
(chloroform) was collected. Then, the organic phase was dehydrated with sodium sulfate 
anhydrous and dried under vacuum or under a stream of nitrogen. 
Methyl-tert-butyl ether extraction
Methyl-tert-butyl ether (MTBE) extraction was performed as described elsewhere.34 Briefly, 
3 mg freeze-dried sample was homogenized in an Ultra Turrax (T18 Basic, IKA) for 2 min 
with 120 µL ice-cold 75% methanol. Then, 300 µL MTBE was added and the mixture was 
shaken for 1 h at room temperature (RT). Phase separation was induced by adding 75 µL 
water. Upon 10 min of incubation at RT, the sample was centrifuged at 12000 g for 15 min, 
at 4 ºC.
Organic and aqueous phases were separately collected and then the organic (upper) phase 
was dehydrated with sodium sulfate anhydrous and dried under vacuum or under a stream 
of nitrogen.
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13
Extraction of free fatty acids 
To remove the free fatty acids from the obtained lipidic extracts using the methods described 
above, chemical extraction was used. Firstly, the fatty acids were extracted with 0.02 N 
sodium carbonate and, after acidification of the aqueous phase with 37% hydrochloric acid, 
the free fatty acids were re-extracted with hexane. The free fatty acid organic solutions were 
then dehydrated and dried as previously referred.
Fatty acids analysis
The fatty acids profile of the extracts was analyzed by GC/MS, using a procedure adapted 
from Sertoglu et al.35 Briefly, the fatty acids were derivatized to their methyl esters (FAMEs). 
For that, 50 µL of the sample or standard solutions, 1 mL methanolic sulfuric acid and 100 µL 
internal standard solution (Tricosanoic acid, C23:0; 500 µg/mL) were added to a digestive 
tube. The transmethylation occurred at 100 ºC for 2 h. After cooling the tubes at RT, 2 mL 
hexane was added. The organic (upper) phase was collected and dehydrated with sodium 
sulfate anhydrous. 100 µL of the sample was transferred to a GC injection vial. To perform 
the analyses, a Scion 436-GC chromatograph (Bruker Daltonics) equipped with a SLB-IL100 
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14
capillary GC Column, 30 m x 0.25 mm x 0.20 μm (Catalog no. 28884-U), was used. The 
sample injection was performed in a split mode at 240 ºC with a 20:1 split ratio. Helium was 
used as carrier gas. The temperature was initially programmed at 50 ºC and held for 5 min, 
followed by an increase to 230 ºC at 3 ºC/min. The identification and quantification of the fatty 
acids were achieved using standard solutions at different concentrations (50, 100, 200, 350 
and 500 mg/L), the Supelco® 37 Component FAME Mix as well as the OpenChrom® software. 
Production and characterization of sardine roe derived-MLVs
MLVs preparation and phospholipid and phosphatidylcholine quantification
MLVs were prepared by the thin film hydration method.36 The dried lipid films obtained after 
organic solvents elimination were hydrated with HEPES buffer and mixed using a vortex to 
produce MLVs, keeping the temperature of the hydrating medium around 37 ºC. 
The phospholipid content was quantified by the Bartlett method37 and the concentration of 
the phospholipids containing choline as the polar group was measured using the LabAssay™ 
Phospholipid. The Bartlett method is based on the colorimetric determination of inorganic 
phosphate. Phospholipids are disrupted with perchloric acid, giving rise to quantifiable free 
inorganic phosphate. Next, the inorganic phosphate is converted to phosphomolybdic acid 
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15
by ammonium molybdate, which is reduced to a blue colored complex by 4-amino-2-naphthyl-
4-sulphonic acid in boiling water. The absorbance was determined at 830 nm in a microplate 
reader (Synergy HT, BioTek).
With the LabAssay™ Phospholipid, phospholipids were hydrolyzed to choline by 
phospholipase D. Afterwards, the choline is oxidized by choline oxidase, producing hydrogen 
peroxide. The hydrogen peroxide leads to the quantitative oxidative condensation of N-ethyl-
N-(2-hydroxy-3-sulfopropyl)-3,5-dimethoxyaniline sodium salt and 4-aminoantipyrine, in the 
presence of peroxidase, producing a blue pigment. The concentration of phosphatidylcholine 
in the sample was determined by measuring the absorbance at 600 nm in the microplate 
reader referred before.
Size distribution, zeta potential and morphology of MLVs
The size, polydispersity index (PDI) and zeta potential of the MLVs in a concentration of  
500 µM were determined at pH 7.4 (HEPES buffer) and at 37 ºC by dynamic light scattering 
(DLS) and laser Doppler micro-electrophoresis, respectively, using a zetasizer (Nano ZS, 
Malvern Instruments Ltd). Liposomes morphology was evaluated using a high-resolution field 
emission scanning electron microscope (FE-SEM; Auriga Compact, Zeiss). Prior to analyses, 
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16
the MLVs concentration was adjusted to 25 µM in the presence of 2% ethanol and placed 
into the surface of a support film of carbon (type-B 400 mesh Cu). 
Differential scanning calorimetry
The thermal properties of the freeze-dried MLVs were determined using a differential 
scanning calorimeter (DSC Q100, TA instruments). Nitrogen gas with a flow rate of 
50 mL/min was purged through the DSC aluminum pan, which contained around 5 mg of 
lyophilized sample. The analyses were performed with a temperature range from - 35 to 100 
ºC, at 5 ºC/ min. Cooling was achieved with a refrigerated cooling system.
Biological assays
Cell culture
L929 cell line was used to evaluate the cytotoxicity of the liposomes. Cells were cultured in 
DMEM, supplemented with 10% heat-inactivated FBS and 1% antibiotic/antimycotic solution 
(100 U/mL penicillin and 100 mg/mL streptomycin). Cells were incubated at 37 °C in 5% CO2 
- 95% air conditions. The culture medium was changed every 2/3 days and the culture was 
split every 7 days. For the determination of the metabolic activity, cell proliferation and total 
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protein content, cells were seeded on 24-well plates at a density of 1 x 105 cells. After 24 h 
in culture, cells were incubated with liposomes at different concentrations in culture medium: 
0, 0.25, 0.50, 1.00, 1.50 and 2.00 mM. Cells incubated with 10 % DMSO in culture medium 
were used as the positive control for cell death. Cells were retrieved after 24, 48 and 72 h. 
Three independent experiments were performed. 
Determination of metabolic activity
L929 metabolic activity was evaluated using the colorimetric method CellTiter 96® AQueous 
One Solution Cell Proliferation Assay, according to the manufacturer’s instructions. This 
assay is based on the bioreduction of a tetrazolium compound, 3-(4,5-dimethylthiazol-2-yl)-
5-(3-carboxymethoxyphenyl)-2-(4-sulphofenyl)-2H-tetrazolium (MTS), into a water-soluble 
brown formazan product in metabolically active cells. The absorbance measured at 490 nm 
(Synergy HT, BioTek) is directly proportional to the number of viable cells in culture. 
Determination of cell proliferation
Cell proliferation was determined using the Quant-iT™ Pico Green® dsDNA Assay Kit, 
according to the manufacturer’s instructions. The fluorescence intensity was measured at 
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excitation and emission wavelengths of 485 ± 20 nm and 528 ± 20 nm, respectively, in a 
microplate reader (Synergy HT, BioTek). The DNA concentration for each sample was 
quantified using a standard curve of DNA concentration (range of 0 – 2 µg/mL) versus 
fluorescence intensity.
Quantification of total protein
Total protein content was quantified using the Micro BCA™ Protein Assay kit, according to 
the manufacturer’s instructions. This colorimetric method uses bicinchoninic acid (BCA) as 
the detection reagent for Cu+, which is formed when Cu2+ is reduced by proteins in an alkaline 
environment. Two molecules of BCA chelate one Cu+ with the production of a purple-colored 
product. This water-soluble complex exhibits a strong absorbance at 562 nm that is linear to 
protein concentration. This parameter was calculated using a standard curve of albumin 
concentration (range of 0 – 40 µg/mL) versus absorbance.
Celecoxib entrapment efficiency
Celecoxib loaded-MLVs prepared from unprocessed samples obtained by MTBE method 
were produced using the thin film hydration method mentioned above. The sardine roe extract 
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was mixed with 1 mg celecoxib, and the MTBE was removed under vacuum or under a stream 
of nitrogen. Non-incorporated celecoxib was separated using Vivaspin® ultrafiltration units, 
by two subsequent centrifugation cycles of 2 h, at 5000 rpm and 5 ºC. 
The concentration of celecoxib encapsulated into MLVs was determined by a HPLC system 
(Merck Hitachi), equipped with a quaternary pump (L-7100), an interface (D-7000), a diode 
array detector (L-7455), and an auto-sampler (L-7200). The procedure was adapted from 
Dong et al.32 A LiChroCART® LiChrospher® 100 RP-18 (4 x 4 mm, 5 µm, Merck) precolumn 
and a LiChroCART® LiChrospher® 100 RP-18 (250 x 4.6 mm, 5 µm, Merck) column were 
used. The analyses were performed at RT, in an isocratic mode, using acetonitrile and 0.1% 
(v/v) acetic acid (65:35) as mobile phase, at a flow rate of 1 mL/min. The injection volume 
was 10 µL and the monitorization of the NSAID was carried out at 250 nm. The content of 
celecoxib in the MLVs was quantified using a standard curve of celecoxib concentration 
(range from 2 to 131 µM) versus the peak area of the chromatograms. Standards and 
samples were diluted with methanol.
The drug entrapment efficiency was calculated using the equation 1. Since there is lipid and 
drug loss during the MLVs production (e.g. celecoxib precipitation, due to its low solubility in 
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aqueous solutions), it was considered the concentration of celecoxib that is effectively 
present in the liposomes suspension to determine the entrapment efficiency. 
𝐸𝑛𝑡𝑟𝑎𝑝𝑚𝑒𝑛𝑡 𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦 (%) = 𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑐𝑒𝑙𝑒𝑐𝑜𝑥𝑖𝑏 𝑒𝑛𝑐𝑎𝑝𝑠𝑢𝑙𝑎𝑡𝑒𝑑 𝑖𝑛𝑡𝑜 𝑀𝐿𝑉𝑠𝐼𝑛𝑖𝑡𝑖𝑎𝑙 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑜𝑓𝑐𝑒𝑙𝑒𝑐𝑜𝑥𝑖𝑏 𝑖𝑛 𝑡ℎ𝑒 𝑀𝐿𝑉𝑠 𝑠𝑢𝑠𝑝𝑒𝑛𝑠𝑖𝑜𝑛 × 100           (1)
In vitro drug release profile
The release of celecoxib from MLVs was determined using dialysis devices (3.5-5 kD of 
molecular weight cut off). The dialysis was performed against HEPES buffer (release 
medium), with constant stirring at 150 rpm and 37 ºC. At 1, 2, 3, 4, 5, 6 and 7 days, 20 µL of 
MLVs was withdrawn to measure the celecoxib content. At the same time-points, the release 
medium was also collected and replaced with an equal volume of HEPES buffer. The 
collected samples were analyzed by HPLC, as previously described.
Statistical analysis 
Statistical analyses were performed using GraphPad Prism software v5.01 (GraphPad 
Software, Inc., USA). To test the assumption of Normality, the Kolmogorov-Smirnov test was 
applied. As the data obtained in the assays used to determine the yields of the extraction 
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methods followed a normal distribution, the statistical significance of the difference between 
the two groups was evaluated by the t-test. -In biological assays, data did not follow a normal 
distribution, being the non-parametric Kruskal-Wallis and Dunn’s multiple comparison tests 
applied to evaluate the statistical significance of the difference between the conditions 
assessed. Differences were considered statistically significant when p<0.05.
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Results
Assessment of sardine roe morphology, histology, and histochemistry
Figure 1 shows the surface morphology of the sardine roe analyzed by SEM. Oocytes with 
different sizes (8 - 350 µm) are visualized, being the size related to the different stages of 
their development. Indeed, in the spawning capable phase of the reproductive cycle of 
sardine, oocytes are in different developmental stages.38 Primary to secondary growth 
oocytes as well as oocyte maturation can be observed in the histological sections presented 
in Figure 2A. Primary growth oocytes (PG) have a large and centrally located nucleus 
surrounded by a cytoplasm densely stained with hematoxylin (the cytoplasm is basophilic at 
this stage). Cortical alveolar (CA) oocytes have unstained empty vacuoles (named yolk 
vesicles) in the cytoplasm, which then migrate to the periphery of the cytoplasm forming first 
a single layer and then several peripheral rows (cortical alveoli). Primary vitellogenic (Vtg1) 
oocytes have small yolk vesicles within their periphery (the yolk vesicles extend 3/4 of the 
distance from the periphery to the perinuclear zone) and oil droplets also appear in the 
ooplasm at this stage; secondary vitellogenic (Vtg2) oocytes present more and larger yolk 
vesicles and oil droplets throughout the cytoplasm; tertiary vitellogenic (Vtg3) oocytes have 
Page 22 of 68
ACS Paragon Plus Environment
ACS Biomaterials Science & Engineering
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
23
numerous large yolk vesicles and the oil droplets surround the nucleus; in mature oocytes, 
the nucleus is dissolved and the ooplasm consists of yolk bodies.39
Strong AB positivity, which indicates the presence of sulfated GAGs, was observed in oocytes 
mainly at the beginning of the development (PG, CA, Vtg1 and Vtg2 oocytes; Figure 2B). In 
Vtg3 and mature oocytes, the staining is stronger at the periphery of the oocytes. A strong 
stain was also obtained in the extracellular space. 
With the MT staining (collagen fibers staining), oocytes of sardine appear unstained (Figure 
2C). 
The presence of neutral lipids was indicated with Oil Red O staining of unfixed fresh samples, 
processed directly in a cryostat. In Figure 2D, it is also possible to observe that the oil deposits 
increase both in size and number throughout development, in both oil droplets and yolk 
vesicles.
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Figure 1 – SEM micrographs of sardine roe, showing oocytes at different stages of 
development: A: 30x. B: 500x.
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Figure 2 – Histological sardine roe sections, showing oocytes at different stages of 
development, using different stains: A: Hematoxylin-eosin. B: Alcian Blue. C: Masson’s 
Trichrome. D: Oil Red O and Hematoxylin. CA: cortical alveolar oocytes; GVBD: germinal 
vesicle breakdown oocytes; PG: primary growth oocytes; Vtg1: primary vitellogenic oocytes; 
Vtg2: secondary vitellogenic oocytes; Vtg3: tertiary vitellogenic oocytes. Scale bar = 200 µm.
Characterization of lipid extracts
Fatty acids profile
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In order to obtain a more cytocompatible lipid fraction, the separation of free fatty acids by 
chemical extraction was performed. Consequently, two samples were evaluated, namely 
unprocessed and processed samples. The fatty acids composition of the lipid extracts derived 
from the unprocessed and processed samples, obtained by both methods, is presented in 
Table 1. About nineteen fatty acids were quantitatively detected in all samples. The 
predominant fatty acids were C16:0, C18:1Δ9trans, C22:6ω3, C18:0, C16:1ω7, C14:0 and 
C20:5ω3. Table 1 shows that saturated fatty acids (SFA) constituted nearly half of the total 
fatty acids in lipids extracted from sardine roe. The abundance of C16:0 accounted for about 
40% in all samples. Monounsaturated fatty acids (MUFA) and PUFA accounted for about 
27% and 14% of total fatty acids, respectively. C18:1Δ9trans, C16:1ω7 and C18:1Δ9cis were 
the most common MUFA. DHA (C22:6ω3) was found to be the major ω3 PUFA, and the third 
major fatty acid in all samples. The proportions of ω6 PUFA were relatively low in all samples 
(< 1% of total fatty acids). Although the percentage of fatty acids is similar in both extraction 
methods, a higher heterogeneity in fatty acids profile was obtained with the BD method (Table 
1). For example, C14:1ω5, C17:1ω8 and C22:1ω11 (MUFA) and C18:2ω6, C20:2ω6 and 
C22:5ω6 (PUFA) were not detected in MTBE-derived lipidic extracts. Chemical extraction 
seems to lead to some loss of fatty acids, such as C20:5ω3 and ω6 PUFA.
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Table 1 - Fatty acids profile of the unprocessed and processed sardine roe extracts obtained 
with BD and MTBE methods. Data are shown in percentage.
BD (%) MTBE (%)
Fatty acids Unprocessed 
sample
Processed 
sample
Unprocessed 
sample
Processed 
sample
SFA
C14:0 5.58 5.54 5.17 4.27
C15:0 0.74 0.89
C16:0 37.99 34.56 47.03 40.73
C17:0 0.90 0.73
C18:0 6.20 21.17 4.37 22.47
Total SFA 51.41 61.27 58.19 67.47
MUFA
C14:1ω5 0.21
C16:1ω7 6.18 5.60 5.88 3.24
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C17:1ω8 0.27
C18:1Δ9trans 19.85 22.39 18.58 17.05
C18:1Δ9cis 3.31 1.93 2.60
C20:1ω9 0.37 0.23
C22:1ω11 0.13
Total MUFA 30.32 27.99 26.62 22.89
PUFA, ω3
C20:5ω3 4.24 4.52
C22:5ω3 0.30
C22:6ω3 12.91 8.39 10.39 5.49
Total ω3 PUFA 17.45 8.39 14.91 5.49
PUFA, ω6
C18:2ω6 0.28 4.16
C20:2ω6 0.09
C20:4ω6 0.33 0.29
C22:5ω6 0.13 2.35
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Total ω6 PUFA 0.83 2.35 0.29 4.16
Characterization of MLVs
Yield of the extraction methods and resulting phospholipid and phosphatidylcholine 
concentrations
The efficiency in lipid extraction of each method in terms of yield and phospholipid and 
phosphatidylcholine concentrations is presented in Table 2. The MTBE method led to a 
significative higher percentage of extracted lipids: 12 and 16% for BD and MTBE, 
respectively, in terms of weight of the freeze-dried samples. Table 2 also shows that, despite 
the higher yield of MTBE, the different solvents used do not significantly influence the 
phospholipids and phosphatidylcholine concentrations.
Table 2 - Yield of the BD and MTBE methods, and concentration of phospholipid (PL) and 
phosphatidylcholine (PC) in the extracts. Data are shown as arithmetic means ± SD.
Extraction 
method
Yield (g/g) [PL] (mmol/g) [PC] (mmol/ g)
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BD 0.12 ± 0.02
5.59 x 10
-2
 ± 1.07 x 10
-
2
4.25 x 10
-2
 ± 1.20 x 10
-
2
MTBE 0.16* ± 0.03
5.32 x 10
-2
 ± 1.53 x 10
-
2
4.66 x 10
-2
 ± 0.92 x 10
-
2
* p<0.05 versus BD method.
MLVs size distribution, zeta potential and morphology
In Table 3 is possible to confer the size, PDI and zeta potential of the produced MLVs using 
lipids obtained by the two extraction methods, submitted or not to chemical extraction. MLVs 
population is heterogeneous, which is in agreement with the respective PDI values (PDI > 
0.2). The zeta potential values indicate that MLVs have a significant negative surface charge 
(Table 3). 
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Table 3 - Diameter, PDI and zeta potential of MLVs produced with different extracts, obtained 
using BD and MTBE methods, submitted or not to chemical extraction. Data are shown as 
arithmetic means ± SD.
Diameter (nm) Area (%)
Extraction method Peak 
1
Peak 2 Peak 3
Peak 
1
Peak 
2
Peak 
3
PDI
Zeta 
Potentia
l (mV)
Unprocesse
d sample
64.3
± 26.4
322.1
± 
109.5
3467.3
± 
1829.1
12 61 28
0.63
± 0.20
-61.3
± 6.8
BD
Processed 
sample
269.21
± 70.2
1302.9
± 
451.1
5089.6
± 
307.1
39 49 12
0.69
± 0.20
-47.1
±8.8
MTBE
Unprocesse
d sample
92.5
± 32.8
508.0
± 
202.4
2943.7
± 
1708.1
12 56 32
0.54
± 0.17
-60.9
±7.1
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Processed 
sample
31.8
± 12.4
161.9
± 83.3
1475.4
± 51.6
8 57 35
0.55
± 0.13
-59.7
±6.5
In Figure 3 is possible to analyze the size distribution of the MLVs, which corroborates the 
DLS data, as well as their spherical shape. 
Figure 3 – FE-SEM micrographs of the MLVs produced with different extracts obtained by BD (A) 
or MTBE (B) methods and submitted (1) or not (2) to chemical extraction. Scale bar = 1 µm.
Phase transition temperature
The thermal properties of MLVs were characterized by DSC. The data showed three 
endothermic peaks for MLVs produced by both extraction methods, and their respective 
unprocessed and processed samples.
For BD method, the DSC curves of unprocessed sample-derived liposomes presented the 
first endothermic peak at -6.83 ± 1.44 ºC, between -22.95 and 1.51 ºC, the second at 15.00 
± 1.58 ºC, between 5.72 – 23.43 ºC, and the third at 30.42 ± 0.80 ºC, between 26.68 – 33.93 
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ºC. Regarding the processed sample-derived liposomes, the first peak appeared at -10.42 ± 
4.90 ºC, temperature range from -20.04 to -1.18 ºC, the second at 11.46 ± 0.96 ºC, 
temperature range from 0.49 – 23.31 ºC, and the third at 30.90 ± 0.44 ºC, temperature range 
from 25.85 – 35.50 ºC. A representative DSC curve is presented in Figure 4.
-40 -20 0 20 40
0
100
200
300
-5.94 16.60 31.68
Temperature (ºC)
H
ea
t F
lo
w
 (m
W
/g
)
Figure 4 – DSC curve of MLVs prepared from the unprocessed sample obtained by the BD 
method.
For MTBE method, the DSC curves of unprocessed sample-derived liposomes showed the 
first peak at -13.75 ± 6.50 ºC, between -18.01 and -0.83 ºC, the second at 18.82 ± 0.61 ºC, 
7.43 – 23.46 ºC, and the third at 27.56 ± 0.35 ºC, 23.91 – 34.56 ºC. In relation to processed 
sample-derived liposomes, three endothermic peaks were also detected: the first peak 
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around -6.48 ºC, temperature range from -8.96 to 16.00 ºC, the second around 21.21 ºC, 
17.98 – 24.58 ºC, and the third around 35.76 ºC, 31.12 – 42.48 ºC.
Biological activity
Metabolic activity and cell proliferation determination
Standard cell biology protocols were used to assess the effect of MLVs on cell metabolic 
activity and proliferation. Regarding metabolic activity, MLVs prepared from unprocessed 
samples obtained by the BD method presented toxicity for L929 cells at the highest tested 
concentrations (1.00, 1.50 and 2.00 mM) at all time-points (24, 48 and 72 h; Figure 5A). The 
cytotoxic effect on L929 metabolic activity was reduced when the fraction of the fatty acids 
was removed by chemical extraction. However, the difference was statistically significant only 
for 0.25 and 0.50 mM concentrations at 24 h. The negative effect over the metabolic activity 
of the cells was reduced using MLVs prepared with lipidic extracts obtained by the MTBE 
method (Figure 5B). The differences between the effect of the unprocessed and processed 
samples-derived liposomes were statistically significant only for concentrations 0.50 (72 h), 
1.00 (24 h) and 2.00 mM (48 h). 
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Figure 5 – Effect of MLVs on L929 cells metabolic activity. Cells were or not (control; dashed 
line corresponding to 100%) incubated with different concentrations (0.25, 0.50, 1.00, 1.50 
and 2.00 mM) of MLVs obtained from BD (A) or MTBE (B) methods extracts, submitted or 
not to chemical extraction, for 24, 48 and 72 h. Data are shown as arithmetic means ± SD. * 
p<0.05 versus control; ** p<0.01 versus control; *** p<0.001 versus control; §§ p<0.01 versus 
unprocessed sample at 0.25 mM; ## p<0.01 versus unprocessed sample at 0.50 mM; && 
p<0.01 versus unprocessed sample at 1.00 mM; %% p<0.01 versus unprocessed sample at 
2.00 mM.
All the tested conditions of liposomes prepared from the lipidic extracts obtained by the BD 
method had a negative effect on L929 cells proliferation (Figure 6A). The chemical extraction 
reduced this effect, namely for the concentrations 0.50 (24 h) and 1.00 mM (72 h), for which 
the difference was statistically significant. Regarding the MLVs obtained by the MTBE 
method, the highest tested concentrations (1.00, 1.50 and 2.00 mM) presented cytotoxicity, 
for all time-points. However, the liposomes produced from extracts obtained by the MTBE 
method had a lower negative effect on cells than those obtained by the BD method. The 
removal of free fatty acids did not significantly influence the effect of MTBE extraction-derived 
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liposomes on cell proliferation (Figure 6B), suggesting that those free fatty acids were not 
cytotoxic. 
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Figure 6 - Effect of MLVs on L929 cells proliferation. Cells were or not (control; dashed line 
corresponding to 100%) incubated with different concentrations (0.25, 0.50, 1.00, 1.50 and 
2.00 mM) of MLVs obtained from BD (A) or MTBE (B) methods extracts, submitted or not to 
chemical extraction, for 24, 48 and 72 h. Data are shown as arithmetic means ± SD. ** p<0.01 
versus control; *** p<0.001 versus control; ## p<0.01 versus unprocessed sample at 0.50 
mM; & p<0.05 versus unprocessed sample at 1.00 mM.
Total protein quantification
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In terms of protein concentration, the effect of the BD method-derived MLVs followed the 
same trend observed in cell metabolic activity and proliferation, that is, it was negative for the 
highest tested concentrations (1.00, 1.50 and 2.00 mM), for all time-points (Figure 7A). The 
protein synthesis was improved with the additional step of free fatty acids removal, and the 
difference was statistically significant for the concentrations 0.50 (24 h), 1.00 (24 and 72 h) 
and 2.00 mM (24 h). As it can be observed in Figure 7B, the MTBE method led to liposomes 
with a lower negative impact on protein synthesis. The processing of the lipidic extracts did 
not have a meaningful effect on this parameter of cell performance.
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Figure 7 – Effect of MLVs on the total protein content of L929 cells. Cells were or not (control; 
dashed line corresponding to 100%) incubated with different concentrations (0.25, 0.50, 1.00, 
1.50 and 2.00 mM) of lipids obtained from BD (A) or MTBE (B) methods extracts, submitted 
or not to chemical extraction, for 24, 48 and 72 h. Data are shown as arithmetic means ± SD. 
** p<0.01 versus control; *** p<0.001 versus control; ### p<0.001 versus unprocessed 
sample at 0.50 mM; & p<0.05 versus unprocessed sample at 1.00 mM; && p<0.01 versus 
unprocessed sample at 1.00 mM; % p<0.05 versus unprocessed sample at 2.00 mM.
Entrapment efficiency and in vitro release profile of celecoxib
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The entrapment efficiency of the celecoxib in MLVs prepared from unprocessed samples 
obtained by the MTBE method was 68.5 ± 17.5%, showing that liposomes present the ability 
to efficiently encapsulate this NSAID. Indeed, the NSAID concentration into MLVs was of 385 
± 145 µM.
Regarding the celecoxib release profile, it was sustained for seven days (Figure 8). During 
this period, the drug released from the MLVs was 72.6 ± 2.2 % (liposomes retained 27.4 % 
of their initial celecoxib content). This drug was not detected in the release medium by HPLC 
analyses during the time studied, probably due to its precipitation.
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Figure 8 – Celecoxib release profile from MLVs prepared from the unprocessed sample 
obtained by the MTBE method, incubated in HEPES buffer at 37 ºC. Data are shown as 
arithmetic means ± SD.
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Discussion
The main aim of the present work was to extract and identify sardine roe-derived lipids for 
the preparation of liposomes with enhanced and advantageous properties. The sardine roe-
derived liposomes were characterized, and their cytotoxicity and drug entrapment ability were 
evaluated to assess their potential to be used as drug delivery systems.
The specie of sardine (Sardina pilchardus) used in this work is a multiple spawning fish, with 
indeterminate annual fecundity, and in which the spawning batch presents diverse oocytes, 
in different developmental stages.16 Roe was obtained from fishes in the spawning capable 
phase of the reproductive cycle. According to Brown-Peterson and collaborators,38 this is the 
third phase in the reproductive cycle of female fishes (immature, developing, spawning 
capable, regressing and regenerating phases) and it is characterized by the simultaneous 
presence of oocytes in any phase of vitellogenesis (CA and vitellogenic oocytes – Vtg1, Vtg2 
and Vtg3) and mature oocytes [early germinal vesicle migration (EGVM), late germinal 
vesicle migration (LGVM), germinal vesicle breakdown (GVBD) and hydration]. Therefore, 
the sardine roe morphology and histology were assessed to characterize the oocytes and 
their stages of development (Figure 1 and Figure 2A). Histological analyses were 
complemented by histochemical staining to evaluate the presence of various classes of 
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compounds. During the spawning period, nutritional compounds, such as lipids, proteins, 
vitamins, and minerals are mobilized to the gonads in order to ensure their maturation40 and, 
consequently, a specific distribution can be observed in the oocytes. 
Staining with AB demonstrates the presence of sulfated GAGs (Figure 2B). Sulfated GAGs 
include chondroitin sulfate, dermatan sulfate, keratan sulfate, heparin, and heparan sulfate, 
which are present in the cell membranes and in the extracellular matrix.41 These complex 
polysaccharides have important roles in diverse biological functions, such as cell growth, 
differentiation, morphogenesis, migration and signaling; lipid transport and metabolism; blood 
coagulation; inflammation; angiogenesis and cancer, through the interaction with various 
proteins (e.g. growth factors, enzymes, cytokines).41-42 Consequently, GAGs can have 
several applications in the pharmaceutical, nutraceutical, and cosmetic fields. Therefore, 
sardine roe may be a potential and alternative source of GAGs.
The MT staining performed in the present work did not reveal the presence of collagen fibers 
(Figure 2C). Although being unexpected, since for instance it is reported that the basement 
membrane of the oocyte is rich in collagen fibers,43 this result can be related to a low 
expression of collagen by the analyzed samples. Indeed, very low expression of the collagen 
genes has been already described for zebrafish oocytes.44 
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Lipid deposits were observed after Oil Red O staining (Figure 2D). This stain reveals the 
presence of neutral lipids, such as squalene and other hydrocarbons, mono-, di-, and 
triglycerides, wax esters, glyceryl ether esters, cholesterol esters, cholesterol or other sterols, 
free fatty acids, and traces of other neutral lipids (e. g. vitamin A esters).45 Neutral lipids 
function mainly as an energy source,46 but also act as a depot of essential structural fatty 
acids.47 Yolk vesicles also stain red in vitellogenic oocytes, which suggest that these 
cytoplasmic inclusions may have neutral lipids. Indeed, yolk vesicles are not only a source of 
proteins, but also of phospholipids and some neutral lipids.48
Lipid extraction from the sardine roe was further performed in the present work. Since fish 
eggs lipids are a mixture of nonpolar and polar lipids, the organic solvents should be 
sufficiently polar to promote high solubility of all classes of lipids. The extraction of all major 
classes of lipids is traditionally performed using a mixture of chloroform, methanol, and water, 
as described by BD28 or Folch.30 Matyash and co-authors29 pioneered a green approach 
using MTBE for lipids extraction. The advantages of MTBE extraction over conventional 
methods also include the low density and high hydrophobicity of MTBE. Consequently, the 
access to the upper lipid-containing organic phase is easier and the contamination by the 
aqueous phase or by the non-extractable insoluble material (at the interface of 
Page 44 of 68
ACS Paragon Plus Environment
ACS Biomaterials Science & Engineering
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
45
water/methanol and chloroform phases in the BD extraction method) is minimized. 
Additionally, when compared with chloroform, MTBE is non-toxic and non-carcinogenic, 
being an environmentally friendly solvent and reducing the health risk for laboratory 
personnel. MTBE is also non-corrosive and chemically stable, does not produce peroxides 
during storage, and presents no risk of modification of labile lipids.
In the present work, BD and MTBE methods were used to extract lipids from sardine roe. 
Additionally, free fatty acids were removed (and not removed) from the lipid fraction by 
chemical extraction due to their reported toxic effect on mammalian cells.49 
To verify if both extraction methods are able to extract a similar lipidic phase, the fatty acid 
profile was analyzed. The content of fatty acids was similar in both extraction methods (Table 
1). However, a higher heterogeneity of fatty acids profile was observed in the extracts 
obtained using the BD method. Since chloroform/methanol mixture presents a relative higher 
polarity than MTBE,50 it can extract more efficiently lipids with a wide range of polarity.51 This 
can explain the absence of the C14:1ω5, C17:1ω8, C18:2ω6, C20:2ω6, C22:5ω6, 
C22:1ω11, C22:5ω3 fatty acids in the MTBE lipidic extract. Chemical extraction also led to 
variations in the fatty acid profile. Regarding BD method, only seven fatty acids existing in 
higher concentration remained after chemical extraction (C14:0, C16:0, C18:0, C16:1ω7, 
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C18:1Δ9trans, C22:5ω6, C22:6ω3), excepting the C20:5ω3 fatty acid (EPA). In relation to 
the MTBE method, eight fatty acids were obtained after chemical extraction (the same of BD 
method plus C18:1Δ9cis fatty acid). The majority of the absent fatty acids were present in 
low concentrations in the unprocessed sample and, consequently, this additional step can 
decrease their concentrations below the detection limit of the quantification method used in 
this work. Overall, SFA comprised around 60% of total fatty acids in all samples, while the 
percentage contribution of MUFA and PUFA was around 27% and 14%, respectively. These 
percentages are slightly different from others reported in the literature.19, 52 However, it is 
difficult to generalize the fatty acid profile of fish species, since it is profoundly influenced by 
several factors, such as stage of the reproductive cycle, age, size, diet, environmental 
temperature, season, and geographical location.40  
The extraction yield of the MTBE method was higher than the one achieved by the BD 
method, but in terms of phospholipids and phosphatidylcholine concentrations, both methods 
are comparable (Table 2). Similar findings have already been reported by other authors.29, 34 
Considering the disadvantages of using the BD method (mentioned above), the MTBE 
method is highly preferred as an alternative green approach. As phosphatidylcholine is the 
predominant phospholipid in fish eggs, its amount was determined.47 Indeed, 
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phosphatidylcholine accounted for approximately 76.0 % and 87.6 % of the total 
phospholipids in the BD and MTBE extracts, respectively.  This is in agreement with a study 
performed by Bandarra and co-authors,53 in which they demonstrated that the proportion of 
phosphatidylcholine in sardine in the fatty season was 85.09 % (w/w).
Envisioning a pharmaceutical application of the extracted lipids, the main objective was to 
produce drug delivery systems, namely sardine roe-derived liposomes. The produced MLVs 
presented considerable heterogeneity in terms of size, a significant negative surface charge 
and a spherical shape (Table 3 and Figure 3). On the one hand, as further processing (e.g. 
extrusion) was not performed after the dispersion of phospholipids into water, a polydisperse 
population of liposomes in terms of size was expected. On the other hand, the negative zeta 
potential of MLVs is most likely related to the presence of anionic phospholipids, such as 
phosphatidylethanolamine (one of the most abundant phospholipids in teleost fishes).47 A 
pronounced non-neutral zeta-potential value is advantageous since the charged particles will 
tend to repel each other reducing the aggregation and thus increasing the suspension 
stability. 
One of the main physical characteristics of the lipid bilayers is the existence of a temperature 
– phase transition temperature – that defines two thermodynamically distinct phases: at a 
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temperature below the phase transition temperature, liposomes are in the gel phase 
(associated to a low fluidity), whereas at a temperature above, the lipid bilayer is in the fluid 
phase (characterized by high fluidity). The phase transition temperature is specific for each 
lipid and, consequently, membranes with a homogeneous composition (e.g. DPPC 
liposomes)54 have a single phase transition temperature, whereas mixtures of natural 
phospholipids, presenting different fatty acids (e.g. egg yolk phosphatidylcholine - EPC), will 
exhibit a complex thermal behavior.55 The phase transition temperature of each phospholipid 
depends on their acyl chain length, degree of unsaturation, and  geometry and location of the 
double bounds along the chain.56 In the present work, despite phosphatidylcholine was the 
predominant phospholipid (Table 2), the fatty acid composition was more complex (Table 1), 
and the different mixtures presented three endothermic peaks at approximately similar 
temperatures (Figure 4). 
The effect of the MLVs obtained by both extraction methods on cell metabolic activity, 
proliferation, and total protein content was concentration-dependent (Figures 5, 6 and 7). A 
superior cytocompatibility was obtained after chemical extraction, particularly for the extracts 
obtained by the BD method. Additionally, the cytocompatibility was higher for MLVs produced 
using phospholipids obtained by the MTBE method than by the BD method. MLVs have been 
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studied regarding the cytocompatibility of the carrier per se. For instance, Ferreira and co-
authors demonstrated that MLVs composed up to 750 µM of EPC did not induce toxicity for 
human fibroblasts.57 In addition, MLVs formed from salmon lecithin did not show any effect 
on neuronal metabolic activity.58
The evaluation of the entrapment efficiency and the in vitro release profile of celecoxib 
indicated that sardine roe-derived MLVs can be used as drug carriers. An entrapment 
efficiency of 68.5 % was obtained. Some studies have shown similar results for this NSAID, 
despite different formulations were used. Deniz and co-authors, for example, prepared 
different liposomal formulations with 1,2-Distearoyl-sn-glycero-3-phosphocholine (DSPC) 
and cholesterol, and the entrapment efficiency of celecoxib in these MLVs were from 82.4 to 
112.0 %. 59 Other celecoxib loaded liposomes, consisting of soya lecithin and cholesterol, 
had an entrapment efficiency of 67.3 %.60 The entrapment efficiency of this NSAID in 
liposomes prepared by Guo et al. was 98.4 %.61 In addition to the entrapment efficiency, the 
effective concentration of the drug into the liposomes is an important parameter to be 
considered.62 In fact, the entrapment efficiency per se can lead to misleading interpretations, 
because it is based on a ratio of concentrations (the concentration of the drug effectively 
entrapped and the concentration initially used). Considering the reported clinically relevant 
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concentrations of celecoxib in the synovial fluid and plasma (0.3 – 10 µM),63-64 the 
concentration of this NSAID entrapped into MLVs (385 ± 145 µM) is able to counteract an 
inflammatory scenario.
The MLVs prepared from unprocessed samples and obtained by the MTBE method were 
able to sustain the release of celecoxib over seven days. After this period of time, 73 % of the 
initial drug content was released. The determination of the celecoxib concentration released from 
liposomes was performed using the drug-loaded liposomes or the release medium. This anti-
inflammatory drug was detected in the MLVs, but it was difficult to find in the medium due to 
its low solubility in aqueous solutions. Indeed, as celecoxib is hydrophobic, it is located in the 
lipid bilayer, interacting with the nonpolar chains of the phospholipids.65 It has been reported 
that MLVs can be readily phagocytized by macrophages.66 Therefore, a controlled delivery 
of celecoxib into the desired cells (i.e. macrophages) can be obtained. The described features 
of the developed liposomes are essential to improve efficacy and to reduce the dosage 
concentration as well as the side effects of the encapsulated drug.  Moreover, the composition 
of the developed MLVs presents an added value in the development of drug delivery systems. 
Indeed, the high level of ω3 PUFA and other important lipids and fat-soluble compounds, 
such as α-tocopherol,67 is certainly advantageous. ω3 PUFA has a wide range of positive 
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effects, including anti-inflammatory properties,68 and the antioxidants (e.g. α-tocopherol) will 
neutralize radical species that are upregulated in inflammation, and can also protect 
liposomes against oxidation.69 Therefore, considering the abovementioned constitution of the 
developed MLVs, a synergistic action with the entrapped drugs can be obtained. To the best 
of our knowledge, the present work is the first reporting the use of sardine roe-derived 
phospholipids to produce liposomes as drug delivery systems.
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Conclusions
Sardine (Sardina pilchardus) roe was used in the present work to extract and identify relevant 
compounds, namely lipids, which were used to produce liposomes. Regarding the morphological and 
histological results, sardines were in the spawning capable phase of the reproductive cycle, which led 
to the observation of oocytes in different stages. Lipids and phospholipids were successfully extracted 
from sardine roe, using BD and MTBE methods. The MTBE method presented a higher extraction 
yield compared with the BD method. Moreover, biological assays indicated that the effect of MLVs 
on L929 cells metabolic activity, proliferation, and protein content was both concentration and 
extraction method-dependent. MLVs obtained using MTBE method-derived lipidic extracts presented 
a higher cytocompatibility than MLVs obtained by the BD method. However, a superior 
cytocompatibility was obtained after the chemical extraction of the extracts, particularly for the BD 
method. Therefore, the BD method as the traditional method for the extraction of lipids from marine 
resources can be efficiently replaced by the MTBE method, which is more environmentally friendly. 
The developed MLVs presented the ability to encapsulate relevant amounts and to control the release 
of the anti-inflammatory celecoxib. Moreover, due to MLVs specific composition, synergistic effects 
with the entrapped drugs are expected.
The developed sardine roe-derived liposomes have therefore a great potential to be used as drug 
delivery systems. 
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